![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7696151 / 118495-118861
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4233 | 143-151 | Disease | denotes | Covid-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T786 | 0-366 | Sentence | denotes | 800 mg once, followed by 600 mg in 6 to 8 h, then 600 mgdaily for 4 additional daysPlacebo group The incidence of new illness compatible with Covid-19 did not differ significantly between the HCQ group (49 of 414 (11.8%)) and the placebo group (58 of 407 (14.3%)); the absolute difference was −2.4 percentage points (95% confidence interval, −7.0 to 2.2; p = 0.35). |